Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer via Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
Yongrong Wu(Xiamen University), Qing Zhou(First Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Wei Xiong(Beijing University of Chinese Medicine), Xinjun Dai(Hunan University of Traditional Chinese Medicine), Zhen Huang(Hunan University of Traditional Chinese Medicine), Qun‐Fang Lin(First Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Xujun You(Guangzhou University of Chinese Medicine), Xuefei Tian(Shanghai Jiao Tong University), Yan Long(Hunan University of Traditional Chinese Medicine), Si Mei(Hunan University of Traditional Chinese Medicine), Yinmei Guo(Hunan University of Traditional Chinese Medicine)
Cited by 31
Related Papers
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype
|Journal of Thoracic Oncology|2020|166
Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2006|156
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
|Clinical Cancer Research|2013|137